LongROAD may track Early Stage Dementia

Researchers have developed models that could predict mild cognitive impairment and dementia with 88 percent accuracy
Researchers have developed models that could predict mild cognitive impairment and dementia with 88 percent accuracy

A fascinating new study from a team of US researchers has used machine learning techniques to develop algorithms that can analyze naturalistic driving data and detect mild cognitive impairment and dementia in a driver. The work is still in the preliminary stages, however, the researchers claim it could be possible in the future to detect early signs of dementia using either a smartphone app or devices incorporated into car software systems. read more

Dry Mouth? An Accidental Cure may be on the Way

Chronic dry mouth often involves inflammation of the salivary glands, which an existing drug has been shown to reduce
Chronic dry mouth often involves inflammation of the salivary glands, which an existing drug has been shown to reduce
ArenaCreative/Depositphotos

Although we may all get a dry mouth from time to time, for some people it can be an ongoing debilitating condition. There could be new hope for such folks, however, thanks to a recent accidental discovery.

read more

WND Exclusive – Will natural COVID immunity be reflected on the ‘vaccine passport’?

from Brent Smith for World Net Daily:

The COVID-19 vaccination is front and center on most American’s minds as they decide whether or not to get it.

But it’s not just the vaccine itself. It’s not even whether the various vaccines are safe – and they appear to be for the vast majority of the population.

Still, many would opt out and not get the vaccine, given the choice. read more

Repurposed Old Drug for New Cancer Treatment

Phenformin, discontinued in the 1970s as a diabetes treatment, is now being investigated as an adjunct to cancer immunotherapies
Phenformin, discontinued in the 1970s as a diabetes treatment, is now being investigated as an adjunct to cancer immunotherapies

A new review article published in the journal Trends in Cancer is presenting a promising case for phenformin, an old diabetes drug related to metformin, being repurposed as an adjunct to new immunotherapy cancer treatments. A phase 1 clinical trial is already underway to test the safety of the combination treatment for skin cancer.

read more

Video Podcast – Is this Dawn of the Planet of the Apes?

Well here we go. Another question of just because we can, doesn’t mean we should.

And even if things “appear” to work out okay, what is the cost that must eventually be paid for whatever we did?

I’m talking about the latest brilliant scientific venture. Scientists have created embryos that are a mix of human and monkey cells.

And to that, one can only ask – What Could Possibly go Wrong?! read more

Boron Hydrogel Helps Muscles Heal

A newly developed hydrogel could greatly accelerate the recovery times for damaged muscles, by flooding the injury site with boron
A newly developed hydrogel could greatly accelerate the recovery times for damaged muscles, by flooding the injury site with boron

 

Over the past few years we’ve seen some interesting examples of how injectable hydrogels can boost the recovery of damaged muscles and tendons, whether by flooding them with stem cells or acting as supporting scaffolds. Scientists in Spain have now developed a hydrogel that releases boron to dramatically accelerate the formation of new muscle fibers. read more

Synthetic Cell Division

I rarely, if ever, comment or add to any of these science or tech articles, but I have to say – this one worries me. Yes, it’s absolutely fascinating, but it’s sci-fi creepy. This seems to me to be the epitome of just because you can, doesn’t mean you should.
Researchers have created a synthetic single-celled organism (not pictured) that can divide properly
Researchers have created a synthetic single-celled organism (not pictured) that can divide properly

For the first time, a team of scientists has created a synthetic single-celled organism that can divide and grow like a regular living cell. This breakthrough could lead to designer cells that can produce useful chemicals on demand or treat disease from inside the body.

read more

Further Proof Covid has become just another Political Weapon

by: Brent Smith

Let’s talk about weapons of war. No, not scary black “assault” rifles. I’m talking about the weapon of disinformation and the war on the people, devised and implemented by the global elite. I’m talking about possibly hundreds of thousands of sick and dead from Covid-19 – most as it turns out, could have been prevented by the simple use of a single drug, Ivermectin.

A drug that was discovered 46 years ago, in 1975, and has been in medical use since 1981, And it is FDA approved, unlike all the new and hastily developed vaccines, that cost billions to produce and distribute. read more

A Brain Cancer Vaccine?

A new vaccine is designed to help train immune cells to target a mutation unique to brain tumors
A new vaccine is designed to help train immune cells to target a mutation unique to brain tumors

A new article published in the journal Nature is reporting promising results from a landmark Phase 1 human trial testing a novel vaccine designed to help a patient’s immune system better target brain tumors. The data suggests the experimental vaccine is safe and stimulates a significant immune response that slows tumor progression. A larger Phase 2 trial is currently being planned. read more

Herd Immunity is Coming Fast and those like Fauci aren’t Going to Like it

by: Brent Smith
Dr. Saint-Fauci is a certifiable nightmare. This guy, who Trump should have sacked in the first weeks, tasted the deliciousness of his “15 minutes of fame.” And since, he has refused to give it up. And like his political oligarch counterparts, he says and does anything to remain relevant, regardless of the cost to businesses and the toll his nonsense has taken on real people. Don’t be surprised if this media whore runs for political office when this is all said and done. And why not – he’s from New York. He would fit right in.

read more